Skip to content
Home/Companies/Biotech/Atlas Molecular Pharma
Atlas Molecular Pharma

Atlas Molecular Pharma

Biotech·Spain·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Atlas Molecular Pharma?

Atlas Molecular Pharma is currently owned by Inveready Asset Management through Inveready Biotech III (2020 vintage), since 2021.

Hand-verified · updated 2026-08-10

Inveready Asset Management
Investor
Inveready Asset Management
Inveready Biotech III · 2020 · Life Sciences VC

Key facts

HQSpain
SectorBiotech
StatusActive
Websiteatlasmolecularpharma.com

More from Inveready Biotech III

Other portfolio companies in the same fund.

Iteria
Active
BiotechSpain· 2026
Pharmacelera
Active
BiotechSpain· 2026
Nanoligent
Active
BiotechSpain· 2025
Disrupt
Disrupt
Active
HealthTechSpain· 2024
Geniova
Geniova
Active
MedTechSpain· 2024
Lev2050
Active
BiotechSpain· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Atlas Molecular Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Atlas Molecular Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue